SPAG5 and cancer: Collectively, the results suggested that FeSiNTs/siSPAG5-mediated SPAG5 silencing had a marked anti-tumor effect by decreasing proliferation, and inducing cancer cell apoptosis and cell cycle arrest in vitro.